{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457818137
| drug_name =
| IUPAC_name =  (3''R'',5a''S'',6''R'',8a''S'',9''R'',10''S'',12''R'',12a''R'')-10-methoxy-3,6,9-trimethyldecahydro-12''H''-3,12-epoxy[1,2]dioxepino[4,3-''i'']-2-benzopyran
| image = artemether.svg
| image2 =Artemether 3D balls.png

<!--Clinical data-->
| tradename = many<ref>{{cite web|title=Artemether - Drugs.com|url=https://www.drugs.com/international/artemether.html|website=www.drugs.com|accessdate=7 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220222347/https://www.drugs.com/international/artemether.html|archivedate=20 December 2016|df=}}</ref>
| Drugs.com = {{drugs.com|international|artemether}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = intramuscular<ref name=Es2014/>

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 71963-77-4
| ATC_prefix = P01
| ATC_suffix = BE02
| ATC_supplemental =  
| PubChem = 68911
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06697
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 62138
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = C7D6T3H22J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02483
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 195280
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1237051
<!--Chemical data-->
| chemical_formula =
| C=16 | H=26 | O=5
| molecular_weight = 298.374 g/mol
| smiles = C[C@@H]1CC[C@@H]3C42OO[C@](C)(CC[C@@H]12)O[C@H]4O[C@H](OC)[C@@H]3C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SXYIRMFQILZOAM-HVNFFKDJSA-N
}}
<!-- Definition and medical uses -->
'''Artemether''' is a medication used for the treatment of [[malaria]].<ref name=Es2014/> The injectable form is specifically used for severe malaria rather than [[quinine]].<ref name=Es2014/> It may not be as effective as [[artesunate]].<ref name=Es2014/> It is given by [[intramuscular|injection in a muscle]].<ref name=Es2014>{{cite journal|last1=Esu|first1=E|last2=Effa|first2=EE|last3=Opie|first3=ON|last4=Uwaoma|first4=A|last5=Meremikwu|first5=MM|title=Artemether for severe malaria.|journal=The Cochrane database of systematic reviews|date=11 September 2014|volume=9|pages=CD010678|pmid=25209020|doi=10.1002/14651858.CD010678.pub2|pmc=4455227}}</ref> It is also available by mouth in combination with [[lumefantrine]], known as [[artemether/lumefantrine]].<ref name=AHFS2016>{{cite web|title=Artemether and Lumefantrine|url=https://www.drugs.com/monograph/artemether-and-lumefantrine.html|publisher=The American Society of Health-System Pharmacists|accessdate=28 November 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220224045/https://www.drugs.com/monograph/artemether-and-lumefantrine.html|archivedate=20 December 2016|df=}}</ref>

<!-- Side effects and mechanism -->
Artemether causes relatively few side effects.<ref name=Kov2015/> An [[arrhythmia|irregular heartbeat]] may rarely occur.<ref name=Kov2015/> While there is evidence that use during [[pregnancy]] may be harmful in animals models, there is no evidence of concerns in humans.<ref name=Kov2015/> The [[World Health Organization]] therefore recommends it use during pregnancy.<ref name=Kov2015/> It is in the [[artemisinin]] class of medication.<ref name=Kov2015>{{cite journal|last1=Kovacs|first1=SD|last2=Rijken|first2=MJ|last3=Stergachis|first3=A|title=Treating severe malaria in pregnancy: a review of the evidence.|journal=Drug safety|date=February 2015|volume=38|issue=2|pages=165–81|pmid=25556421|pmc=4328128|doi=10.1007/s40264-014-0261-9}}</ref>

<!-- History, society and culture -->
Artemether has been studied since at least 1981 and been in medical use since 1987.<ref>{{cite book|last1=Rao|first1=Yi|last2=Zhang|first2=Daqing|last3=Li|first3=Runhong|title=Tu Youyou and the Discovery of Artemisinin: 2015 Nobel Laureate in Physiology or Medicine|date=2016|publisher=World Scientific|isbn=9789813109919|page=162|url=https://books.google.com/books?id=nmZtDQAAQBAJ&pg=PA162|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170910151644/https://books.google.com/books?id=nmZtDQAAQBAJ&pg=PA162|archivedate=2017-09-10|df=}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> The wholesale cost in the [[developing world]] is between 0.38 and 16.47 USD per vial.<ref>{{cite web|title=Artemether|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=ART80A&s_year=2014&year=2014&str=80%20mg%2Fml&desc=Artemether&pack=new&frm=AMPOULE&rte=INJ&class_code2=06%2E5%2E3%2E1&supplement=&class_name=%2806%2E5%2E3%2E1%29Antimalarial%20medicines%2C%20for%20curative%20treatment%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=1 January 2016}}</ref> The combination form cost between 100 and 200 USD for a course of treatment in the United States.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=45}}</ref>

==Medical uses==
Artemether is an antimalarial drug for uncomplicated malaria caused by &nbsp;[[Plasmodium falciparum|P. falciparum]] (and chloroquine-resistant [[Plasmodium falciparum|P. falciparum]]) or chloroquine-resistant [[Plasmodium vivax|P. vivax]] parasites.<ref>{{Cite journal|last=Makanga|first=Michael|last2=Krudsood|first2=Srivicha|date=2009-10-12|title=The clinical efficacy of artemether/lumefantrine (Coartem)|journal=Malaria Journal|volume=8|issue=Suppl 1|pages=S5|doi=10.1186/1475-2875-8-S1-S5|issn=1475-2875|pmc=2760240|pmid=19818172}}</ref> Artemether can also be used to treat severe malaria.<ref>{{cite journal|last1=Esu|first1=E|last2=Effa|first2=EE|last3=Opie|first3=ON|last4=Uwaoma|first4=A|last5=Meremikwu|first5=MM|title=Artemether for severe malaria.|journal=The Cochrane database of systematic reviews|date=Sep 11, 2014|volume=9|pages=CD010678|pmid=25209020|doi=10.1002/14651858.CD010678.pub2|pmc=4455227}}</ref>

The [[World Health Organization]] recommends the treatment of uncomplicated [[Plasmodium falciparum|P. falciparum]] with [[artemisinin-based combination therapy]].<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK294441/|title=TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA|last=Information|first=National Center for Biotechnology|last2=Pike|first2=U. S. National Library of Medicine 8600 Rockville|last3=MD|first3=Bethesda|last4=Usa|first4=20894|date=2015-01-01|publisher=World Health Organization|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170910151644/https://www.ncbi.nlm.nih.gov/books/NBK294441/|archivedate=2017-09-10|df=}}</ref> Given in combination with [[lumefantrine]], it may be followed by a 14 day regimen of [[primaquine]] to prevent relapse of ''P. vivax''&nbsp;or&nbsp;''P. ovale'' malarial parasites and provide a complete cure.<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK294428/|title=TREATMENT OF UNCOMPLICATED MALARIA CAUSED BY P. VIVAX, P. OVALE, P. MALARIAE OR P. KNOWLESI|last=Information|first=National Center for Biotechnology|last2=Pike|first2=U. S. National Library of Medicine 8600 Rockville|last3=MD|first3=Bethesda|last4=Usa|first4=20894|date=2015-01-01|publisher=World Health Organization|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170910151644/https://www.ncbi.nlm.nih.gov/books/NBK294428/|archivedate=2017-09-10|df=}}</ref>

Artemether can also be used in treating and preventing trematode infections of [[schistosomiasis]] when used in combination with [[praziquantel]].<ref>{{Cite journal|last=Pérez del Villar|first=Luis|last2=Burguillo|first2=Francisco J.|last3=López-Abán|first3=Julio|last4=Muro|first4=Antonio|date=2012-01-01|title=Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis|journal=PloS One|volume=7|issue=9|pages=e45867|doi=10.1371/journal.pone.0045867|issn=1932-6203|pmc=3448694|pmid=23029285}}</ref>

Artemether is rated category C by the FDA based on animal studies where artemisinin derivatives have shown an association with fetal loss and deformity. Some studies, however, do not show evidence of harm.<ref>{{cite journal|vauthors=Dellicour S, Hall S, Chandramohan D, Greenwood B |title=The safety of artemisinins during pregnancy: a pressing question|journal=Malaria J|year= 2007|volume=6|pages=15|doi=10.1186/1475-2875-6-15}}</ref><ref>{{cite journal|vauthors=Piola P, Nabasumba C, Turyakira E |title=Efficacy and safety of artemether—lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial|journal=Lancet Infect Dis|volume=10|issue=11|pages=762&ndash;769|year=2010|doi=10.1016/S1473-3099(10)70202-4|display-authors=etal}}</ref>

== Side effects ==
Possible side effects include cardiac effects such as bradycardia and [[QT interval]] prolongation.<ref name="Artemether">{{Cite web|url=http://www.antimicrobe.org/drugpopup/artemether.htm|title=Artemether|website=www.antimicrobe.org|access-date=2016-11-09|deadurl=no|archiveurl=https://web.archive.org/web/20170223123545/http://www.antimicrobe.org/drugpopup/artemether.htm|archivedate=2017-02-23|df=}}</ref> Also, possible central nervous system toxicity has been shown in animal studies.<ref>{{Cite web|url=http://apps.who.int/medicinedocs/en/d/Jh2922e/2.5.10.html#Jh2922e.2.5.10|title=WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Malaria: Artemether|website=apps.who.int|access-date=2016-11-09|deadurl=no|archiveurl=https://web.archive.org/web/20161110043655/http://apps.who.int/medicinedocs/en/d/Jh2922e/2.5.10.html#Jh2922e.2.5.10|archivedate=2016-11-10|df=}}</ref><ref name=Askling2012>{{Cite journal|last=Askling|first=Helena H.|last2=Bruneel|first2=Fabrice|last3=Burchard|first3=Gerd|last4=Castelli|first4=Francesco|last5=Chiodini|first5=Peter L.|last6=Grobusch|first6=Martin P.|last7=Lopez-Vélez|first7=Rogelio|last8=Paul|first8=Margaret|last9=Petersen|first9=Eskild|date=2012-01-01|title=Management of imported malaria in Europe|url=https://dx.doi.org/10.1186/1475-2875-11-328|journal=Malaria Journal|volume=11|pages=328|doi=10.1186/1475-2875-11-328|issn=1475-2875|pmc=3489857|pmid=22985344}}</ref>

== Drug interactions ==
Plasma artemether level was found to be lower when the combination product was used with lopinavir/ritonavir.<ref name=Askling2012/> There is also decreased drug exposure associated with concurrent use with efavirenz or nevirapine.<ref>{{Cite journal|last=Van geertruyden|first=J.-P.|title=Interactions between malaria and human immunodeficiency virus anno 2014|journal=Clinical Microbiology and Infection|volume=20|issue=4|pages=278–285|doi=10.1111/1469-0691.12597|pmc=4368411|pmid=24528518}}</ref><ref>{{Cite journal|last=Kiang|first=Tony K. L.|last2=Wilby|first2=Kyle J.|last3=Ensom|first3=Mary H. H.|date=2013-10-26|title=Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals|url=https://link.springer.com/article/10.1007/s40262-013-0110-5|journal=Clinical Pharmacokinetics|language=en|volume=53|issue=2|pages=141–153|doi=10.1007/s40262-013-0110-5|issn=0312-5963}}</ref>

Artemether/lumefantrine should not be used with drugs that inhibit [[CYP3A4]].<ref name=Stover2012>{{Cite journal|last=Stover|first=Kayla R.|last2=King|first2=S. Travis|last3=Robinson|first3=Jessica|date=2012-04-01|title=Artemether-Lumefantrine: An Option for Malaria|url=http://aop.sagepub.com/content/46/4/567|journal=Annals of Pharmacotherapy|language=en|volume=46|issue=4|pages=567–577|doi=10.1345/aph.1Q539|issn=1060-0280|pmid=22496476}}</ref>

Hormonal contraceptives may not be as efficacious when used with artemether/lumefantrine.<ref name=Stover2012/>

==Pharmacology==

=== Mechanism of action ===
Artemether is an [[artemisinin]] derivative and the mechanism of action for artemisinins is unknown.<ref name=Saeed2016/><ref name=Guo2016/>

One of the proposed mechanisms is that through inhibiting anti-oxidant and metabolic enzymes, artemistinin derivatives inflict oxidative and metabolic stress on the cell. Some pathways affected may concern glutathione and glucose metabolism. As a consequence, lesions and reduced growth of the parasite may result.<ref name=Saeed2016>{{cite journal|last1=Saeed|first1=ME|last2=Krishna|first2=S|last3=Greten|first3=HJ|last4=Kremsner|first4=PG|last5=Efferth|first5=T|title=Antischistosomal activity of artemisinin derivatives in vivo and in patients.|journal=Pharmacological research|date=August 2016|volume=110|pages=216–26|pmid=26902577|doi=10.1016/j.phrs.2016.02.017}}</ref>

Another possible mechanism of action suggests that arteristinin drugs exert their cidal action through inhibiting PfATP6. Since PfATP6 is an enzyme regulating cellular calcium concentration, its malfunctioning will lead to intracellular calcium accumulation, which in turns causes cell death.<ref name=Guo2016>{{Cite journal|last=Guo|first=Zongru|date=2016-03-01|title=Artemisinin anti-malarial drugs in China|url=http://www.sciencedirect.com/science/article/pii/S2211383516300089|journal=Acta Pharmaceutica Sinica B|volume=6|issue=2|pages=115–124|doi=10.1016/j.apsb.2016.01.008|pmc=4788711|pmid=27006895}}</ref>

===Pharmacokinetics===
Absorption of artemether is improved 2- to 3-fold with food. It is highly bound to protein (95.4%). Peak concentrations of artemether are seen 2 hours after administration.<ref name=USlabel2015>{{cite web|title=Coartem Label|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022268s012lbl.pdf|publisher=FDA|date=March 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161117151239/http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022268s012lbl.pdf|archivedate=2016-11-17|df=}}</ref>

Artemether is metabolized in the human body to the active metabolite, dihydroartemisinin, primarily by hepatic enzymes CYP3A4/5.<ref name=USlabel2015/> Both the parent drug and active metabolite are eliminated with a half-life of about 2 hours.<ref name=USlabel2015/>

==Chemistry==
Artemether is a [[methyl ether]] derivative of [[artemisinin]], which is a peroxide-containing [[lactone]] isolated from the antimalarial plant ''[[Artemisia annua]]''. It is also known as dihydroartemisinin methyl ether, but its [[International Union of Pure and Applied Chemistry|correct chemical nomenclature]] is (+)-(3-alpha,5a-beta,6-beta,8a-beta, 9-alpha,12-beta,12aR)-decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin.
It is a relatively lipophilic and unstable drug,<ref>{{cite journal | last1 = De Spiegeleer | first1 = B.M.J. | last2 = D'Hondt | first2 = M. | last3 = Vangheluwe | first3 = E. | last4 = Vandercruyssen | first4 = K. | last5 = De Spiegeleer | first5 = B.G.I. | last6 = Jansen | first6 = H. | last7 = Koijen | first7 = I. | last8 = Van Gompel | first8 = J. | year = 2012 | title = Relative response factor determination of artemether degradants with a dry heat stress approach | url = | journal = Journal of Pharmaceutical and Biomedical Analysis | volume = 70 | issue = | pages = 111–116 | doi=10.1016/j.jpba.2012.06.002}}</ref> which acts by creating reactive free radicals in addition to affecting the  membrane transport system of the plasmodium organism.<ref name="Artemether"/>

== References ==
{{Reflist|32em}}

{{Antimalarials}}

[[Category:Antimalarial agents]]
[[Category:Organic peroxides]]
[[Category:Sesquiterpenes]]
[[Category:Trioxanes]]
[[Category:Chinese discoveries]]
[[Category:World Health Organization essential medicines]]
[[Category:RTT]]